DSP Top 100 Equity Fund
Large Cap Fund- An open ended equity scheme predominantly investing in large cap stocks
DSP Top 100 Equity Fund
Large Cap Fund- An open ended equity scheme predominantly investing in large cap stocks
Fund Manager

Gopal Agrawal
Total work experience of over 20 years
Managing the Scheme since October 2018

Jay Kothari (Dedicated Fund Manager for overseas investments)
Total work experience of 14 years.
Managing the Scheme from August 2018

Inception date

Mar 10, 2003

Benchmark

S&P BSE 100 (TRI)

NAV AS ON APRIL 30, 2020
Regular Plan  
Growth: ₹ 177.368
Direct Plan  
Growth: ₹ 185.950
Total aum

₹ 2,082 Cr

Monthly average aum

₹ 1,915 Cr

Portfolio Turnover Ratio(Last 12 months):

0.32

3 Year Risk Statistics:
Standard Deviation : 23.49%
Beta : 1.12
R-Squared : 94.92%
Sharpe Ratio : -0.24
Month End Expense Ratio
Regular Plan : 2.19%
Direct Plan : 1.43%
Fund Category

Large Cap

17 Yr 1 Mn

Fund Details as on 30 April 2020
AUM as on 30 April 2020 (₹ in Cr) 2,082
Exit Load

Holding Period:
< 12 months: 1%
>= 12 months: Nil

Name of Instrument% to Net Assets
EQUITY & EQUITY RELATED
Listed / awaiting listing on the stock exchanges
Banks 28.39%
✔ HDFC Bank Limited 10.31%
✔ ICICI Bank Limited 7.85%
✔ Kotak Mahindra Bank Limited 4.07%
✔ Axis Bank Limited 3.21%
State Bank of India 2.52%
The Federal Bank Limited 0.43%
Finance 13.73%
✔ Bajaj Finance Limited 4.97%
HDFC Life Insurance Company Limited 2.07%
ICICI Lombard General Insurance Company Limited 2.03%
SBI Life Insurance Company Limited 1.55%
Housing Development Finance Corporation Limited 1.40%
ICICI Prudential Life Insurance Company Limited 0.89%
Mahindra & Mahindra Financial Services Limited 0.49%
Equitas Holdings Limited 0.34%
Petroleum Products 8.91%
✔ Reliance Industries Limited 5.92%
Bharat Petroleum Corporation Limited 2.27%
Hindustan Petroleum Corporation Limited 0.72%
Software 7.15%
Infosys Limited 3.11%
Tata Consultancy Services Limited 2.44%
HCL Technologies Limited 1.61%
Cement 6.56%
✔ UltraTech Cement Limited 4.09%
Shree Cement Limited 2.47%
Pharmaceuticals 6.29%
✔ Dr. Reddy's Laboratories Limited 3.16%
Indoco Remedies Limited 1.43%
Sun Pharmaceutical Industries Limited 1.08%
Jubilant Life Sciences Limited 0.62%
Telecom - Services 4.71%
✔ Bharti Airtel Limited 4.71%
Auto 4.47%
Maruti Suzuki India Limited 3.16%
Eicher Motors Limited 0.96%
Mahindra & Mahindra Limited 0.35%
Construction Project 4.02%
✔ Larsen & Toubro Limited 3.64%
NCC Limited 0.37%
Consumer Non Durables 3.43%
Britannia Industries Limited 1.72%
Hindustan Unilever Limited 1.71%
Retailing 2.18%
Avenue Supermarts Limited 2.18%
Ferrous metals 1.87%
Tata Steel Limited 1.87%
Tata Steel Limited - Partly Paid Shares *
Consumer Durables 1.61%
Titan Company Limited 1.61%
Non - Ferrous metals 1.09%
Hindalco Industries Limited 0.85%
Vedanta Limited 0.23%
Auto Ancillaries 0.98%
Motherson Sumi Systems Limited 0.98%
Transportation 0.66%
Adani Ports and Special Economic Zone Limited 0.66%
Power 0.64%
NTPC Limited 0.64%
Gas 0.37%
GAIL (India) Limited 0.37%
Textile Products 0.22%
Himatsingka Seide Limited 0.22%
Total 97.28%
MONEY MARKET INSTRUMENTS
TREPS / Reverse Repo Investments / Corporate Debt Repo 1.94%
Total 1.94%
Cash & Cash Equivalent
Net Receivables/Payables 0.78%
Total 0.78%
GRAND TOTAL 100.00%

✔Top 10 Holdings
Less than 0.01%
Classification of % of holdings based on Market Capitalisation: Large-Cap 93.38%, Mid Cap 0.92%, Small-Cap 2.98%. Large Cap: 1st -100th company in terms of full market capitalization Mid Cap: 101st -250th company in terms of full market capitalization Small Cap: 251st company onwards in terms of full market capitalization


Growth of Rs. 1 L invested at inception: 17.74 L

SIP Returns(In %)
  10 yr5 yr 3 yr SI*
*SI - Since inception5.29(0.80)(7.43)11.66

Outperformed Benchmark TRI (calendar year) S&P BSE 100 TRI
31%


Rolling Return
  10 yr 5 yr 3 yr 1 yr
Minimum 4.2 -3.2 -8.0 -47.2
Maximum 27.6 50.9 73.6 141.6
Average 14.8 15.4 17.6 20.9
% times negative returns -- 0.5 1.6 19.7
% of times returns are in
excess of 7%
98.3 92.0 81.4 67.5
Past performance may or may not be sustained in future and should not be used as a basis for comparison with other investments. Returns are for Regular Plan - Growth Option Click here for performance in SEBI prescribed format.

Large Cap: 1st -100th company in terms of full market capitalization
Mid Cap: 101st -250th company in terms of full market capitalization
Small Cap: 251st company onwards in terms of full market capitalization.
 
Positions Increased
Stock
Cement
UltraTech Cement Limited
Telecom - Services
Bharti Airtel Limited
Banks
ICICI Bank Limited
 
Positions Decreased
Stock
Petroleum Products
Reliance Industries Limited
Pharmaceuticals
Dr. Reddy's Laboratories Limited
Consumer Non Durables
Hindustan Unilever Limited
Banks
Axis Bank Limited
Note: The above position change is compared to last month-end data.
Rebalances below 0.05 % are not considered.
Investment Objective

The primary investment objective is to seek to generate long term capital appreciation from a portfolio that is substantially constituted of equity and equity related securities of large cap companies. From time to time, the fund manager will also seek participation in other equity and equity related securities to achieve optimal portfolio construction.
There is no assurance that the investment objective of the Scheme will be realized.

Product Labelling

This Open Ended Scheme is suitable for investors who are seeking*
• Long-term capital growth
• Investment in equity and equity-related securities predominantly of large cap companies

* Investors should consult their financial advisors if in doubt whether the product is suitable for them.